Planta Med 2003; 69(12): 1150-1152
DOI: 10.1055/s-2003-818008
Letter
© Georg Thieme Verlag Stuttgart · New York

Demethylbellidifolin Inhibits Adhesion of Monocytes to Endothelial Cells via Reduction of Tumor Necrosis Factor alpha and Endogenous Nitric Oxide Synthase Inhibitor Level

De-Jian Jiang1 , Jun-Lin Jiang1 , Gui-Shan Tan2 , Zhi-Zhuang Huang1 , Han-Wu Deng1 , Yuan-Jian Li1
  • 1Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha, China
  • 2Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Central South University, Changsha, China
This study was supported by a grant from the Provincial Natural Science Foundation of Hunan, China, No. 02jjy2046
Weitere Informationen

Publikationsverlauf

Received: May 7, 2003

Accepted: August 30, 2003

Publikationsdatum:
29. Januar 2004 (online)

Abstract

The effect of demethylbellidifolin (DMB), a major compound of Swertia davidi Franch, on the adhesion of monocytes to endothelial cells induced by oxidized low-density lipoprotein (ox-LDL) was studied. Adhesion of monocytes to endothelial cells was induced by treatment with ox-LDL (100 μg/mL) for 48 h. Levels of tumor necrosis factor-α (TNF-α) and asymmetric dimethylarginine (ADMA, an endogenous inhibitor of NOS) in conditioned medium and the activity of dimethylarginine dimethylaminohydrolase (DDAH) in endothelial cells were measured. DMB (3 or 10 μmol/L) significantly inhibited the adhesion of monocytes to endothelial cells, attenuated an increase in levels of TNF-α and ADMA, and a decrease in the activity of DDAH by ox-LDL. The present results suggest that DMB inhibits the increased adhesion of monocytes to endothelial cells induced by ox-LDL, and that the effect of DMB is related to reduction of the ADMA concentration via reduction of TNF-α  production in cultured endothelial cells treated with ox-LDL.

References

  • 1 Böger R H, Bode-Böger S M, Szuba A, Tsao P S, Chan J R, Tangphao O, Blaschke T F, Cooke J P. Asymmetric dimethylarginine: a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.  Circulation. 1998;  98 1842-7
  • 2 Yu X J, Li Y J, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits.  Life Sci. 1994;  54 753-8
  • 3 Rus H, Niculescu F, Vlaicu R. Tumor necrosis factor-α in human arterial wall with atherosclerosis.  Atherosclerosis. 1991;  89 247-54
  • 4 Tanaka H, Sukhova G, Schwartz D, Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-α but not interleukin-1 or basic fibroblast growth factor.  Arterioscler Thromb Vasc Biol. 1996;  16 12-18
  • 5 Chen Y H, Lin S J, Chen J W, Ku H H, Chen Y L. Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits.  Br J Pharmacol. 2002;  135 37-47
  • 6 Ito A, Tsao P S, Adimoolam S, Kimoto M, Ogawa T, Cooke J P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.  Circulation. 1999;  99 3092-5
  • 7 Peres V, Nagem T J, De oliveira F F. Tetraoxygenated naturally occurring xanthones.  Phytochemistry. 2000;  55 683-710
  • 8 Madan B, Singh I, Kumar A, Prasad A K, Raj H G, Parmar V S. Xanthones as inhibitors of microsomal lipid peroxidation and TNF-alpha induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs).  Bioorg Med Chem. 2002;  10 3431-6
  • 9 Jiang D J, Jiang J L, Tan G S, Du Y H, Xu K P, Li Y J. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine.  N-S Arch Pharmacol;. 2003;  367 600-6
  • 10 Cooke J P. Does ADMA cause endothelial dysfunction?.  Arterioscler Thromb Vasc Biol. 2000;  20 2032-7

Yuan-Jian Li, MD

Department of Pharmacology

School of Pharmaceutical Sciences

Central South University

Xiang-Ya Road #88

Changsha 410078

P. R. China

Telefon: +86-731-4805441

Fax: +86-731-2650442

eMail: yuan_jianli@yahoo.com

    >